Discovery of a dual CCR2/CCR5 antagonist with a superior cardiovascular profile for the treatment of autoimmune diseases

被引：0

作者：

Hughes, Robert O. ^{[1
]}

Rogier, D. Joseph ^{[1
]}

Devraj, Rajesh ^{[1
]}

Xue, Chu-Biao ^{[2
]}

Cao, Ganfeng ^{[2
]}

Turner, Steven R. ^{[1
]}

Morton, Philip A. ^{[1
]}

Keys, Kelly ^{[1
]}

Covington, Maryanne ^{[2
]}

Bond, Brian R. ^{[1
]}

Yu, Ying ^{[1
]}

Meade, Holly ^{[1
]}

Hood, William F. ^{[1
]}

Roeberds, Steve ^{[1
]}

Newton, Robert ^{[2
]}

Metcalf, Brian ^{[2
]}

机构：

[1] Pfizer Res & Dev, Cambridge, MA 02451 USA

[2] Incyte Corp, Willmington, DE 19880 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

26-MEDI

引用

页数：1

共 50 条

[11] Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist
Zheng, Changsheng
Cao, Ganfeng
Xia, Michael
Feng, Hao
Glenn, Joseph
Anand, Rajan
Zhang, Ke
Huang, Taisheng
Wang, Anlai
Kong, Ling
Li, Mei
Galya, Laurine
Hughes, Robert O.
Devraj, Rajesh
Morton, Phillip A.
Rogier, D. Joseph
Covington, Maryanne
Baribaud, Fred
Shin, Niu
Scherle, Peggy
Diamond, Sharon
Yeleswaram, Swamy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
Xue, Chu-Biao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1442 - 1446
[12] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Laura Fantuzzi
Maria Tagliamonte
Maria Cristina Gauzzi
Lucia Lopalco
Cellular and Molecular Life Sciences, 2019, 76 : 4869 - 4886
[13] Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
Lefebvre, Eric
Moyle, Graeme
Reshef, Ran
Richman, Lee P.
Thompson, Melanie
Hong, Feng
Chou, Hsin-I
Hashiguchi, Taishi
Plato, Craig
Poulin, Dominic
Richards, Toni
Yoneyama, Hiroyuki
Jenkins, Helen
Wolfgang, Grushenka
Friedman, Scott L.
PLOS ONE, 2016, 11 (06):
[14] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
Fantuzzi, Laura
Tagliamonte, Maria
Gauzzi, Maria Cristina
Lopalco, Lucia
CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (24) : 4869 - 4886
[15] An azirine solid-state photodegradant of the CCR2/CCR5 dual antagonist BMS-813160
Ayers, Sloan
La Cruz, Thomas
Park, Hyunsoo
Ramirez, Antonio
Hritzko, Benjamin
Sarjeant, Amy
Lin, Ziqing
Zaretsky, Serge
Huang, Yande
Zang, Jia
Yuill, Elizabeth M.
Fenster, Michael D. B.
TETRAHEDRON LETTERS, 2022, 110
[16] Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model
Okamoto, Masayuki
Suzuki, Takeshi
Watanabe, Nobuhide
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (03) : 210 - 212
[17] A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune disease
Zhao, Qihong
Pang, Jian
McIntyre, Kim
Gilloolly, Kathleen
Townsend, Robert
Postelnek, Jennifer
Grafstrom, Robert
He, Bokang
Ford, Gregory
Conarello, Stacey
Xie, Jenny
Davies, Paul
Barrish, Joel
Trzaskos, James
Salter-Cid, Luisa
Mckinnon, Murray
Mandlekar, Sandhya
Carter, Percy
JOURNAL OF IMMUNOLOGY, 2009, 182
[18] CCR2/CCR5 antagonist cenicriviroc reduces colonic inflammation and fibrosis in experimental colitis
Song, Xin
Jiang, Chensheng
Yu, Mengli
Lu, Chao
He, Xinjue
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1597 - 1605
[19] CCR5 and CCR2 gene polymorphisms in hypertensive patients
Mettimano, M
Specchia, ML
Ianni, A
Arzani, D
Ricciardi, G
Savi, L
Romano-Spica, V
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2003, 60 (01) : 19 - 21
[20] MEDI 163-CCR2/CCR5 Antagonists: A new approach for the treatment of autoimmune diseases
Miltz, Wolfgang
Loetscher, Pius
Janser, Philipp
Hersperger, Rene
Hiestand, Peter
Meingassner, Josef
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235

← 1 2 3 4 5 →